Skip to main content

Galliprant® (grapiprant tablets) for Dogs

Treat canine osteoarthritis (OA) inflammation and pain at home with a once-daily chewable tablet.

Approved for use in dogs older than 9 months of age and greater than 8 lbs.

What is canine osteoarthritis?

OA is a painful and progressive disease that causes inflammation and swelling in a dog’s joints.

How do you know if your dog has canine osteoarthritis? Look for the following symptoms:

  • Slowing down
  • Limping
  • Hip swaying
  • Bunny hopping
  • Difficulty with stairs
  • Struggling to get up

If your dog shows any of these warning signs, schedule an appointment with your vet.

Treating OA pain and inflammation earlier can improve long-term outlook.1

Osteoarthritis in younger dogs is more common than you may think. In fact, 40% of dogs younger than 4 years of age had radiographic signs of OA.2

OA management is most effective when started early1. Galliprant offers treatment flexibility, and from a young age, to help dogs enjoy more moments.3,*

Find a vet near you to see if Galliprant is right for your dog.

Save When Purchasing Galliprant®

Get $20 off of 30 tablets and $60 off of 90 tablets.
Use the code GPT2025 to claim your rebate.

Indication

Galliprant controls pain and inflammation associated with osteoarthritis in dogs.


Important Safety Information

For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Please see product label for full prescribing information.

Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-25-1050

© 2025 Elanco or its affiliates.